Differential Clinical Outcomes of Palliative Radiotherapy among Different Molecular Subtypes of Metastatic Breast Cancer: A Prospective Study

20260 citationsJournal Articlegold Open Access

Authors

Naveen Thimmaiah · Kidwai Memorial Institute of Oncology

Nirupama Naveen · Kidwai Memorial Institute of Oncology

Ayushee Saini · Medanta The Medicity

Uday Krishna · Apollo Proton Cancer Centre

Mageshraja Kannan · Kidwai Memorial Institute of Oncology

Tanvir Pasha · Kidwai Memorial Institute of Oncology

Poojar Sridhar

Abstract

Luminal subtypes have better local control and progression-free survival post-HPRT compared to TNBC and HER2+ subtypes, which can further be used to stratify radiotherapy fractionation schedules.

Topics & Keywords

Breast Cancer Treatment Studies Brain Metastases and Treatment Cancer Treatment and Pharmacology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Asian Pacific Journal of Cancer Prevention

Volume 27, Issue 3, pp. 1029-1035

DOI: 10.31557/apjcp.2026.27.3.1029

Field-Weighted Citation Impact: 0.00